Related references
Note: Only part of the references are listed.The clinical phenotypes of autoimmune hepatitis: A comprehensive review
Qixia Wang et al.
JOURNAL OF AUTOIMMUNITY (2016)
Using GWAS to identify genetic predisposition in hepatic autoimmunity
G. J. Webb et al.
JOURNAL OF AUTOIMMUNITY (2016)
Genome-Wide Association Study Identifies Variants Associated With Autoimmune Hepatitis Type 1
Ynto S. de Boer et al.
GASTROENTEROLOGY (2014)
Hepatitis mouse models: from acute-to-chronic autoimmune hepatitis
Muhammed Yuksel et al.
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY (2014)
Pathogen Infection as a Possible Cause for Autoimmune Hepatitis
Urs Christen et al.
INTERNATIONAL REVIEWS OF IMMUNOLOGY (2014)
Intrahepatic regulatory T cells in autoimmune hepatitis are associated with treatment response and depleted with current therapies
Richard Taubert et al.
JOURNAL OF HEPATOLOGY (2014)
TNF-α is essential in the induction of fatal autoimmune hepatitis in mice through upregulation of hepatic CCL20 expression
Satoru Iwamoto et al.
CLINICAL IMMUNOLOGY (2013)
Splenectomy Prolongs the Effects of Corticosteroids in Mouse Models of Autoimmune Hepatitis
Ryutaro Maruoka et al.
GASTROENTEROLOGY (2013)
Genetic predisposition and environmental danger signals initiate chronic autoimmune hepatitis driven by CD4+ T cells
Matthias Hardtke-Wolenski et al.
HEPATOLOGY (2013)
Molecular mimicry rather than identity breaks T-cell tolerance in the CYP2D6 mouse model for human autoimmune hepatitis
Janine Ehser et al.
JOURNAL OF AUTOIMMUNITY (2013)
Medullary thymic epithelial cell depletion leads to autoimmune hepatitis
Anthony J. Bonito et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Systematic identification of trans eQTLs as putative drivers of known disease associations
Harm-Jan Westra et al.
NATURE GENETICS (2013)
IL12-Mediated Liver Inflammation Reduces the Formation of AAV Transcriptionally Active Forms but Has No Effect over Preexisting AAV Transgene Expression
Irene Gil-Farina et al.
PLOS ONE (2013)
T-bet: a bridge between innate and adaptive immunity
Vanja Lazarevic et al.
NATURE REVIEWS IMMUNOLOGY (2013)
IFN-γ is reciprocally involved in the concurrent development of organ-specific autoimmunity in the liver and stomach
Satoru Iwamoto et al.
AUTOIMMUNITY (2012)
Diagnosis and Management of Autoimmune Hepatitis
Michael P. Manns et al.
HEPATOLOGY (2010)
Autoimmune hepatitis: new paradigms in the pathogenesis, diagnosis, and management
Ye H. Oo et al.
HEPATOLOGY INTERNATIONAL (2010)
Treatment options for autoimmune hepatitis: A systematic review of randomized controlled trials
Mieke M. H. Lamers et al.
JOURNAL OF HEPATOLOGY (2010)
Gene Therapy Using IL-12 Family Members in Infection, Auto-Immunity, and Cancer
Maximilian J. Waldner et al.
CURRENT GENE THERAPY (2009)
Breaking tolerance to the natural human liver autoantigen cytochrome P450 2D6 by virus infection
Martin Holdener et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Expression of PD-1, PD-L1, and PD-L2 in the liver in autoirnmune liver diseases
Norikazu Mataki et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
α-Galactosylceramide-induced liver injury in mice is mediated by TNF-α but independent of Kupffer cells
M Biburger et al.
JOURNAL OF IMMUNOLOGY (2005)
T cell immunity in autoimmune hepatitis
Y Ichiki et al.
AUTOIMMUNITY REVIEWS (2005)
T helper cell fate specified by kinase-mediated interaction of T-bet with GATA-3
ES Hwang et al.
SCIENCE (2005)
A murine model of type 2 autoimmune hepatitis: Xenoimmunization with human antigens
P Lapierre et al.
HEPATOLOGY (2004)
Necroinflammatory liver disease in BALB/c background, TGF-β1-Deficient mice requires CD4+ T cells
LA Rudner et al.
JOURNAL OF IMMUNOLOGY (2003)
DNA vaccination breaks tolerance for a neo-self antigen in liver: A transgenic murine model of autoimmune hepatitis
I Djilali-Saiah et al.
JOURNAL OF IMMUNOLOGY (2002)
Genetic regulation of autoimmune disease:: BALB/c background TGF-β1-deficient mice develop necroinflammatory IFN-γ-dependent hepatitis
JD Gorham et al.
JOURNAL OF IMMUNOLOGY (2001)
Murine concanavalin A-induced hepatitis is prevented by interleukin 12 (IL-12) antibody and exacerbated by exogenous IL-12 through an interferon-γ-dependent mechanism
F Nicoletti et al.
HEPATOLOGY (2000)
IL-12 plasmid-enhanced DNA vaccination against carcinoembryonic antigen (CEA) studied in immune-gene knockout mice
K Song et al.
GENE THERAPY (2000)
Share Paper
